LauraSzczesniakMDPhD(She/Her)

Physician

Dr. Szczesniak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Laura Szczesniak is an emergency medicine specialist located in Wauwatosa, WI. She completed her residency in emergency medicine at the Medical College of Wisconsin Affiliated Hospitals from 2023 to 2026, after graduating from SUNY Upstate Medical University in 2023. She holds a BS in Chemistry, earned Summa Cum Laude, from SUNY Geneseo. Her research work includes publications on topics such as buprenorphine treatments and the Bok interactome, with her articles appearing in journals like Harm Reduction Journal, Journal of Addiction Medicine, The American Journal of Drug and Alcohol Abuse, and Frontiers in Cell and Developmental Biology. Her work on these topics has been cited multiple times in other publications.

Medical College of Wisconsin Affiliated HospitalsResidency, Emergency Medicine, 2023 - 2026
SUNY Upstate Medical UniversityClass of 2023
SUNY GeneseoBS, Chemistry, Summa Cum Laude, 2011 - 2015

PubMed

Ivabradine exposures reported to United States poison centers 2015-2023.
Laura Szczesniak, Stephen Thornton, Ryan Feldman, Justin Corcoran
Clinical Toxicology. 2025-02-24
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder.
Laura Szczesniak, Sarah Britton, Theresa Baxter Rn, Ross Sullivan
Harm Reduction Journal. 2024-06-07
3 citations
Microdose Induction of Buprenorphine in a Patient Using Tianeptine.
Laura Szczesniak, Ross Sullivan
Journal of Addiction Medicine. 2022-06-17